Picture loading failed.

Anti-LINGO1 therapeutic antibody (Pre-made Opicinumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Opicinumab (BIIB033) is a fully human monoclonal antibody designed for the treatment of multiple sclerosis, acute optic neuritis (AON), and other associated demyelinating diseases. A biologic drug, it is designed to function as a LINGO-1 protein antagonist, known as “Anti-Lingo-1”.

Order informatioin

Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-407-1mg 1mg 3090
GMP-Bios-ab-407-10mg 10mg 21890
GMP-Bios-ab-407-100mg 100mg 148000
GMP-Bios-ab-407-xmg ≥100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Anti-LINGO1 therapeutic antibody (Pre-made Opicinumab biosimilar,Whole mAb)
INN Name Opicinumab
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusDiscontinued
100% SI Structure4oqt:HL
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2015
Year Recommended2016
CompaniesBiogen Idec;Dyax;Biogen
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedMultiple sclerosis;Optic neuritis
Development TechDyax Human Phage Display